Clinigence Holdings, Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was USD 5.57 million compared to USD 0.350032 million a year ago. Net loss was USD 1.9 million compared to net income of USD 1.76 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to basic earnings per share from continuing operations of USD 0.34 a year ago. Basic loss per share was USD 0.04 compared to basic earnings per share of USD 0.34 a year ago. For the nine months, sales was USD 12.87 million compared to USD 1.19 million a year ago. Net loss was USD 9.09 million compared to net income of USD 0.86073 million a year ago. Basic loss per share from continuing operations was USD 0.27 compared to basic earnings per share from continuing operations of USD 0.17 a year ago. Basic loss per share was USD 0.27 compared to basic earnings per share of USD 0.18 a year ago.